# Research Audit: AI2 CodeScientist
**Status:** Rigorous Experimentation for Update 2.9 (The "Scientific Method" Pillar)  
**Reference:** [allenai/codescientist](https://github.com/allenai/codescientist)

---

## 🧐 Conceptual Overview
CodeScientist automates the entire scientific research lifecycle expressed as code. It moves the agent board from "Feature Building" to "Scientific Discovery," using ArXiv-driven ideation and statistically significant meta-analysis.

## 🚀 Key Technical Insights from Implementation

### 1. ArXiv-Driven Ideation
*   **The Logic:** Mutates ideas from existing scientific literature to propose novel, testable hypotheses for code improvement.
*   **Application:** Enable the **Researcher Agent** to ingest ArXiv abstracts related to "Social Contagion" and "Multi-Modal Fusion." The agent board can then propose experiments that humans haven't even thought of yet.

### 2. Three-Stage Pilot System
*   **The Logic:** Tiered execution (Mini-Pilot -> Pilot -> Full Experiment) to catch bugs early and minimize costs.
*   **Application:** Formalize the **SelfMirror Sandbox**. Any change to the core fusion weights must pass a "Mini-Pilot" (syntax/basic logic) before entering the "Full Experiment" (Backtest Harness).

### 3. Automated Synthesis & Reporting
*   **The Logic:** Groups multiple trial results into a meta-analysis and generates a LaTeX scientific report.
*   **Application:** Implement an **Autonomous R&D Log**. The board will autonomously generate weekly reports (in Markdown/PDF) summarizing its research findings, proven improvements, and statistical confidence levels.

## 🤝 Strategic Implementation for Update 2.9

1.  **Experiment Builder:** New skill in `src/skills/` that scaffolds a structured experiment script with Mini-Pilot checks.
2.  **ArXiv Ingestion Layer:** Module to feed the Researcher Agent with the latest relevant frontier research.
3.  **Meta-Analysis Reporter:** A post-backtest step that distills results into a scientific narrative.

---
**Decision:** Essential for v2.0 maturity. Phase 13 will transform the board into a world-class R&D organization.
